Get the Stockscreener App
1.13
3.67%
0.04
After Hours:
1.09
-0.04
-3.54%
Tela Bio Inc stock is traded at $1.13, with a volume of 464.58K.
It is up +3.67% in the last 24 hours and up +89.18% over the past month.
TELA Bio Inc a commercial-stage medical technology company focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
See More
Previous Close:
$1.09
Open:
$1.09
24h Volume:
464.58K
Relative Volume:
1.95
Market Cap:
$50.59M
Revenue:
$80.28M
Net Income/Loss:
$-38.83M
P/E Ratio:
-1.3585
EPS:
-0.8318
Net Cash Flow:
$-28.67M
1W Performance:
+44.87%
1M Performance:
+89.18%
6M Performance:
-5.83%
1Y Performance:
+13.57%
1-Day Range:
$1.08
$1.27
1-Week Range:
$0.7504
$1.27
52-Week Range:
$0.5011
$2.20
Tela Bio Inc Stock (TELA) Company Profile
Name
Tela Bio Inc
Sector
Industry
Phone
484-320-2930
Address
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
Compare TELA vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TELA
Tela Bio Inc
|
1.13 | 48.79M | 80.28M | -38.83M | -28.67M | -0.8318 |
ABT
Abbott Laboratories
|
87.17 | 152.48B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
295.25 | 111.40B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
77.79 | 100.53B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
55.98 | 84.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.91 | 48.04B | 6.30B | 1.07B | 1.34B | 1.8406 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-21-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-31-22 | Initiated | Lake Street | Buy |
| Dec-03-19 | Initiated | Canaccord Genuity | Buy |
| Dec-03-19 | Initiated | JMP Securities | Mkt Outperform |
| Dec-03-19 | Initiated | Jefferies | Buy |
| Dec-03-19 | Initiated | Piper Jaffray | Overweight |
View All
Tela Bio Inc Stock (TELA) Latest News
LIQUIFIX offers new approach to mesh fixation, TELA Bio claims - Traders Union
Analysts Have Conflicting Sentiments on These Healthcare Companies: Phathom Pharmaceuticals (PHAT), TELA Bio (TELA) and Nanobiotix (NBTX) - The Globe and Mail
TELA Bio Reshapes Board, Appoints New Chairman, Directors - The Globe and Mail
Lake Street Maintains TELA Bio(TELA.US) With Buy Rating, Maintains Target Price $2 - Moomoo
Piper Sandler Maintains TELA Bio(TELA.US) With Hold Rating, Maintains Target Price $1 - Moomoo
$19M Q1 tops TELA Bio outlook as 4 new directors join - Stock Titan
TELA Bio Taps Turnaround Titans for Board in Bold Push for Profitability - BriefGlance
TELA Stock Price, Quote & Chart | TELA BIO INC (NASDAQ:TELA) - ChartMill
Axos, Gallagher and TELA Bio post strong growth and strategic moves - MSN
TELA Bio: Departing Directors Are Chmn of the Bd Doug Evans, Kurt Azarbarzin, Vince Burgess, Federica O'Brien >TELA - Moomoo
TELA Bio (NASDAQ: TELA) outlines 2026 virtual meeting, board refresh and larger equity plan - Stock Titan
Leadership shake-up at TELA Bio (NASDAQ: TELA) as new chair named - Stock Titan
TELA Bio Announces Strategic Board Refreshment with Four - GlobeNewswire
TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues - ChartMill
TELA Price Today: TELA Bio, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
TELA Bio (TELA) price target decreased by 34.78% to 2.30 - MSN
TELA Bio Schedules Q1 2026 Earnings Release and Call - MyChesCo
TELA Bio (TELA) Gets a Buy from Canaccord Genuity - The Globe and Mail
Tela Bio targets at least 8% revenue growth in 2026 while advancing commercial transformation - MSN
TELA Bio to Announce First Quarter 2026 Financial Results - The Manila Times
TELA Bio plans a May 12 webcast to unpack quarterly results - Stock Titan
TELA Bio launches OviTex Long-Term Resorbable with PLGA reinforcement to advance robotic surgery platforms - Traders Union
TELA Bio (TELA) Stock Bonus Issue (Technical Strength) 2026-04-15High Interest Stocks - UBND thành phố Hải Phòng
TELA Bio urges case-specific approaches for hernia repair at Intuitive Connect - Traders Union
What is the sentiment around TELA Bio (TELA) Stock | Price at $0.59, Down 0.12%AI Powered Stock Picks - Newser
Volume Report: What analysts say about TELA Bio Inc stock2026 Spike Watch & Reliable Breakout Forecasts - baoquankhu1.vn
Aug Levels: What analysts say about TELA Bio Inc stock2026 Key Highlights & Daily Market Momentum Tracking - baoquankhu1.vn
Market Wrap: Will TELA Bio Inc benefit from AI trendsM&A Rumor & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Stock Report: Is TELA Bio Inc attractive at current valuation2026 Spike Watch & Stepwise Swing Trade Plans - baoquankhu1.vn
Can TELA Bio (TELA) Stock Beat the Market | Price at $0.63, Up 5.47%Attention Driven Stocks - Newser
Investment Analysts’ Weekly Ratings Updates for TELA Bio (TELA) - Defense World
TELA Q4 2025 Earnings: TELA Bio Inc. tops EPS views, no revenue logged - Newser
TELA Bio unveils new hernia solution with focus on simplicity and reliability - Traders Union
Aug Fed Impact: Is TELA Bio Inc a stock for growth or value investors2026 AllTime Highs & Safe Entry Trade Signal Reports - baoquankhu1.vn
Q3 2025 TELA Bio Inc Earnings Call Transcript - GuruFocus
Citizens Jmp Issues Pessimistic Forecast for TELA Bio (NASDAQ:TELA) Stock Price - Defense World
Published on: 2026-03-28 00:22:27 - baoquankhu1.vn
TELA Bio, Inc.Common stock - FinancialContent
TELA Bio analysts cut their forecasts after Q4 results - msn.com
TELA Bio, Inc. (NASDAQ:TELA) Q4 2025 earnings call transcript - MSN
Citizens cuts Tela Bio stock price target on commercial transition By Investing.com - Investing.com South Africa
Citizens cuts Tela Bio stock price target on commercial transition - Investing.com UK
Canaccord Genuity Group Lowers TELA Bio (NASDAQ:TELA) Price Target to $2.00 - Defense World
TELA Bio, Inc. (TELA) reports Q4 loss, lags revenue estimates - MSN
Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE), TELA Bio (TELA) and Nuvalent (NUVL) - The Globe and Mail
EPS Watch: What analysts say about TELA Bio Inc stock2026 Volatility Report & Consistent Income Trade Ideas - baoquankhu1.vn
TELA Bio (NASDAQ:TELA) Given New $1.00 Price Target at Piper Sandler - Defense World
TELA Bio (NASDAQ:TELA) Given New $2.00 Price Target at Lake Street Capital - Defense World
Piper Sandler cuts TELA Bio stock price target on lowered outlook - Investing.com Australia
Tela Bio Inc Stock (TELA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.41%
0.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):